This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Persistent disparities in dialysis patient outcomes among Medicare beneficiaries point to the importance of greater health equity. A study by Westat Insight’s Dominick Esposito, Ph.D., and coauthors Andrew Breck, Ph.D., Jeffrey Marr, and Marc Turenne, Ph.D., explored the End-Stage Renal Disease (ESRD) Quality Incentive Program (QIP) and social risk factors to bring health disparities to light.
Published in a recent issue of Medical Care, the article, The Role of Social Risk Factors in Dialysis Quality and Patient Outcomes Under a Medicare Quality Incentive Program, found no evidence of widening disparities in dialysis care or patient outcomes, which is a longstanding and well-publicized concern with value-based purchasing programs.
In a recent editorial in the same journal, Health Equity in Dialysis Facilities: A Requirement or an Afterthought?, authors note: “The manuscript by Breck and colleagues does an important service to the field by moving our understanding of ESRD care one step forward.”
Westat Insight is a wholly owned subsidiary of Westat and branded as “Westat Insight.”